Kamada (KMDA) Research & Development (2012 - 2026)
Kamada's (KMDA) quarterly Research & Development came in at $2.2 million in Q1 2026, down 48.63% YoY from $4.2 million in Q1 2025, and down 24.64% on a QoQ basis from $2.9 million in Q4 2025.
Kamada (KMDA) Research & Development (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Research & Development data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Research & Development fell 48.63% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (down 25.38% YoY) and the FY2025 annual result came in at $13.0 million, down 14.42% from the prior year.
- Research & Development retreated to $2.2 million in Q1 2026, from $2.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $4.4 million in Q1 2022 to a low of $3118.0 in Q3 2022.
- A 5-year average of $2.5 million and a median of $2.9 million in 2025 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development plunged 99.93% — and 2024, when it surged 132830.98%.
- Tracing KMDA's Research & Development over 5 years: stood at $3.0 million in 2022, then climbed by 8.29% to $3.2 million in 2023, then fell by 17.47% to $2.7 million in 2024, then grew by 8.27% to $2.9 million in 2025, then retreated by 24.64% to $2.2 million in 2026.
- The last three Research & Development figures came in at $2.2 million (Q1 2026), $2.9 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Kamada | 455.98 Mn | 426.51 Mn | 22.47 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 3,219.00 |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 4,803.00 |
| Mar 31, 2024 | 4.30 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 4.28 Mn |
| Mar 31, 2023 | 3,231.00 |
| Dec 31, 2022 | 2.99 Mn |
| Sep 30, 2022 | 3,118.00 |
| Jun 30, 2022 | 2.64 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 3.45 Mn |
| Sep 30, 2021 | 2.55 Mn |